Product
Vicagrel
1 clinical trial
1 indication
Indication
Acute Coronary SyndromeClinical trial
A Phase 1, Open-label, Randomized, Multiple-dose, Crossover Pharmacokinetic/Pharmacodynamic Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 PhenotypesStatus: Completed, Estimated PCD: 2022-11-03